NJ State Employees Deferred Compensation Plan’s Johnson & Johnson JNJ Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-41,969	Closed	-$7.78M	–	204
2025 Q3	$7.78M	Sell	41,969 -4,730	-10%	-$810K	0.86%	14
2025 Q2	$7.13M	Sell	46,699 -7,000	-13%	-$1.08M	0.84%	16
2025 Q1	$8.91M	Hold	53,699	–	–	1.14%	11
2024 Q4	$7.77M	Hold	53,699	–	–	0.94%	13
2024 Q3	$8.7M	Hold	53,699	–	–	1.03%	13
2024 Q2	$7.85M	Hold	53,699	–	–	0.98%	14
2024 Q1	$8.49M	Hold	53,699	–	–	1.08%	12
2023 Q4	$8.42M	Hold	53,699	–	–	1.16%	10
2023 Q3	$8.36M	Sell	53,699 -1,301	-2%	-$215K	1.27%	9
2023 Q2	$9.1M	Hold	55,000	–	–	1.31%	9
2023 Q1	$8.53M	Hold	55,000	–	–	1.32%	7
2022 Q4	$9.72M	Hold	55,000	–	–	1.57%	6
2022 Q3	$8.98M	Hold	55,000	–	–	1.54%	5
2022 Q2	$9.76M	Hold	55,000	–	–	1.59%	5
2022 Q1	$9.75M	Hold	55,000	–	–	1.32%	6
2021 Q4	$9.41M	Hold	55,000	–	–	1.18%	7
2021 Q3	$8.88M	Hold	55,000	–	–	1.21%	7
2021 Q2	$9.06M	Hold	55,000	–	–	1.2%	7
2021 Q1	$9.04M	Hold	55,000	–	–	1.29%	7
2020 Q4	$8.66M	Hold	55,000	–	–	1.34%	8
2020 Q3	$8.19M	Hold	55,000	–	–	1.47%	7
2020 Q2	$7.74M	Hold	55,000	–	–	1.45%	7
2020 Q1	$7.21M	Hold	55,000	–	–	1.65%	7
2019 Q4	$8.02M	Hold	55,000	–	–	1.36%	8
2019 Q3	$7.12M	Hold	55,000	–	–	1.3%	8
2019 Q2	$7.66M	Buy	55,000 +7,000	+15%	+$969K	1.37%	7
2019 Q1	$6.71M	Sell	48,000 -2,000	-4%	-$268K	1.22%	7
2018 Q4	$6.45M	Hold	50,000	–	–	1.34%	7
2018 Q3	$6.91M	Hold	50,000	–	–	1.18%	5
2018 Q2	$6.07M	Hold	50,000	–	–	1.08%	5
2018 Q1	$6.41M	Hold	50,000	–	–	1.14%	6
2017 Q4	$6.99M	Hold	50,000	–	–	1.21%	5
2017 Q3	$6.5M	Hold	50,000	–	–	1.18%	5
2017 Q2	$6.62M	Hold	50,000	–	–	1.25%	5
2017 Q1	$6.23M	Hold	50,000	–	–	1.18%	7
2016 Q4	$5.76M	Hold	50,000	–	–	1.14%	7
2016 Q3	$5.91M	Hold	50,000	–	–	1.22%	7
2016 Q2	$6.07M	Hold	50,000	–	–	1.29%	6
2016 Q1	$5.47M	Hold	50,000	–	–	1.16%	7
2015 Q4	$5.14M	Hold	50,000	–	–	1.05%	10
2015 Q3	$4.67M	Sell	50,000 -20,000	-29%	-$1.93M	1.01%	10
2015 Q2	$6.82M	Hold	70,000	–	–	1.33%	4
2015 Q1	$7.04M	Hold	70,000	–	–	1.36%	4
2014 Q4	$7.32M	Hold	70,000	–	–	1.43%	5
2014 Q3	$7.46M	Hold	70,000	–	–	1.52%	5
2014 Q2	$7.32M	Hold	70,000	–	–	1.45%	5
2014 Q1	$6.88M	Hold	70,000	–	–	1.41%	5
2013 Q4	$6.41M	Hold	70,000	–	–	1.31%	5
2013 Q3	$6.07M	Hold	70,000	–	–	1.32%	5
2013 Q2	$6.01M	Buy	+70,000	New	+$5.94M	1.38%	6

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's JNJ Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 41,969 shares — an estimated $7.78M sold.

NJ State Employees Deferred Compensation Plan first reported a position in JNJ in Q2 2013 and held it in 50 quarters. The position peaked at $9.76M in Q2 2022. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

NJ State Employees Deferred Compensation Plan reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 41,969 Johnson & Johnson shares in Q4 2025, an estimated $7.78M.
NJ State Employees Deferred Compensation Plan first reported a position in Johnson & Johnson in Q2 2013 and held it in 50 quarters.
NJ State Employees Deferred Compensation Plan's Johnson & Johnson position peaked at $9.76M in Q2 2022.
4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.